Share

February 14, 2012; 78 (7) Articles

Fatal PML associated with efalizumab therapy

Insights into integrin αLβ2 in JC virus control

N. Schwab, J.C. Ulzheimer, R.J. Fox, T. Schneider-Hohendorf, B.C. Kieseier, C.M. Monoranu, S.M. Staugaitis, W. Welch, S. Jilek, R.A. Du Pasquier, W. Brück, K.V. Toyka, R.M. Ransohoff, H. Wiendl
First published February 1, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182478d4b
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
630

Share

Article Information

vol. 78 no. 7 458-467
DOI: 
https://doi.org/10.1212/WNL.0b013e3182478d4b
PubMed: 
22302546
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received January 19, 2011
  • Accepted July 6, 2011
  • First Published February 1, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. N. Schwab, PhD,
    2. J.C. Ulzheimer, MD,
    3. R.J. Fox, MD,
    4. T. Schneider-Hohendorf, MSc,
    5. B.C. Kieseier, MD,
    6. C.M. Monoranu, MD,
    7. S.M. Staugaitis, MD, PhD,
    8. W. Welch, MD,
    9. S. Jilek, PhD,
    10. R.A. Du Pasquier, MD,
    11. W. Brück, MD,
    12. K.V. Toyka, MD,
    13. R.M. Ransohoff, MD* and
    14. H. Wiendl, MD*
  1. N. Schwab, PhD,
  2. J.C. Ulzheimer, MD,
  3. R.J. Fox, MD,
  4. T. Schneider-Hohendorf, MSc,
  5. B.C. Kieseier, MD,
  6. C.M. Monoranu, MD,
  7. S.M. Staugaitis, MD, PhD,
  8. W. Welch, MD,
  9. S. Jilek, PhD,
  10. R.A. Du Pasquier, MD,
  11. W. Brück, MD,
  12. K.V. Toyka, MD,
  13. R.M. Ransohoff, MD* and
  14. H. Wiendl, MD*
  1. From the Department of Neurology–Department of Inflammatory Diseases of the Nervous System and Neurooncology (N.S., T.S.-H., H.W.), University of Münster, Germany; Department of Neurology (N.S., J.C.U., T.S.-H., K.V.T., H.W.) and Department of Pathology, Division of Neuropathology (C.M.M.), University of Würzburg, Germany; Neurological Clinic (J.C.U.), Bad Mergentheim, Germany; Mellen Center for Multiple Sclerosis, Neurological Institute (R.J.F., R.M.R.), Departments of Neurosciences and Anatomic Pathology (S.M.S.), and Neuroinflammation Research Center, Lerner Research Institute (R.M.R.), Cleveland Clinic Foundation, Cleveland, OH; Department of Neurology (B.C.K.), University of Düsseldorf, Germany; Topeka Neurology Associates (W.W.), Topeka, KS; Divisions of Immunology and Allergy and of Neurology (S.J., R.A.D.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and Institute of Neuropathology (W.B.), University of Göttingen, Germany.
  1. Correspondence & reprint requests to Prof. Wiendl: heinz.wiendl{at}ukmuenster.de
View Full Text

Article usage

Article usage: February 2012 to May 2023

AbstractFullPdfSource
Feb 2012176954144Highwire
Mar 20124031742Highwire
Apr 20121971314Highwire
May 20121641117Highwire
Jun 201294611Highwire
Jul 20126542Highwire
Aug 201252911Highwire
Sep 20123553Highwire
Oct 20124442Highwire
Nov 2012511514Highwire
Dec 20125743Highwire
Jan 20138525Highwire
Feb 2013411310Highwire
Mar 20134413Highwire
Apr 20134884Highwire
May 20134623Highwire
Jun 20132632Highwire
Jul 20131622Highwire
Aug 20133955Highwire
Sep 20132110Highwire
Oct 20132556Highwire
Nov 20132802Highwire
Dec 20132522Highwire
Jan 20142230Highwire
Jan 20140144pmc
Feb 20142630Highwire
Mar 20142111Highwire
Apr 20142512Highwire
May 2014241211Highwire
Jun 20141433Highwire
Jul 20142511Highwire
Aug 20141712Highwire
Sep 20141111Highwire
Oct 20142301Highwire
Nov 20141310Highwire
Dec 20142523Highwire
Jan 20153941Highwire
Jan 20150213pmc
Feb 20152033Highwire
Feb 20150116pmc
Mar 20151801Highwire
Mar 2015072pmc
Apr 20152001Highwire
Apr 20150114pmc
May 20151301Highwire
May 2015085pmc
Jun 20151632Highwire
Jun 201501410pmc
Jul 20153601Highwire
Jul 2015064pmc
Aug 20151823Highwire
Aug 20150117pmc
Sep 20151801Highwire
Sep 20150138pmc
Oct 20151213Highwire
Oct 20150157pmc
Nov 20155011Highwire
Nov 20150152pmc
Dec 20152300Highwire
Dec 20150265pmc
Jan 20162933Highwire
Jan 20160145pmc
Feb 20162100Highwire
Feb 2016042pmc
Mar 20161211Highwire
Mar 20160126pmc
Apr 20163311Highwire
Apr 20160113pmc
May 20161442Highwire
May 2016050pmc
Jun 20161510Highwire
Jun 20160215pmc
Jul 20161300Highwire
Jul 2016032pmc
Aug 20162211Highwire
Aug 2016091pmc
Sep 20162100Highwire
Sep 2016092pmc
Oct 20162001Highwire
Oct 20160102pmc
Nov 20162831Highwire
Nov 20160122pmc
Dec 20162022Highwire
Dec 20160115pmc
Jan 20172410Highwire
Jan 2017084pmc
Feb 2017800Highwire
Feb 20170119pmc
Mar 20171800Highwire
Mar 20170186pmc
Apr 20171900Highwire
Apr 2017488pmc
May 20171621Highwire
May 2017277pmc
Jun 20171000Highwire
Jun 20178129pmc
Jul 2017900Highwire
Jul 2017366pmc
Aug 20171300Highwire
Aug 2017266pmc
Sep 2017511Highwire
Sep 2017377pmc
Oct 2017800Highwire
Oct 20170810pmc
Nov 20171500Highwire
Nov 201742025pmc
Dec 20171000Highwire
Jan 20181400Highwire
Feb 20181923Highwire
Mar 20181230Highwire
Apr 20181500Highwire
Apr 201811313pmc
May 2018911Highwire
Jun 20181400Highwire
Jun 2018179pmc
Jul 2018510Highwire
Aug 2018700Highwire
Aug 20184108pmc
Sep 20181000Highwire
Oct 20181400Highwire
Nov 20181420Highwire
Dec 20181311Highwire
Jan 20191011Highwire
Feb 20191010Highwire
Mar 20191401Highwire
Apr 20191501Highwire
May 20192000Highwire
Jun 20191401Highwire
Jul 20191730Highwire
Aug 20192310Highwire
Sep 20191900Highwire
Oct 20191922Highwire
Nov 20192222Highwire
Dec 2019952Highwire
Jan 20201200Highwire
Feb 2020710Highwire
Mar 20201000Highwire
Apr 20201310Highwire
May 2020800Highwire
Jun 20202220Highwire
Jul 20201010Highwire
Aug 2020500Highwire
Sep 20202200Highwire
Oct 20201800Highwire
Nov 20202510Highwire
Dec 20202202Highwire
Jan 20212834Highwire
Feb 20211431Highwire
Mar 20211900Highwire
Apr 20211700Highwire
May 20211721Highwire
Jun 20211000Highwire
Jul 20212510Highwire
Aug 20212300Highwire
Sep 20211310Highwire
Oct 20213410Highwire
Nov 20211510Highwire
Dec 20213622Highwire
Jan 20222721Highwire
Feb 20221900Highwire
Mar 20221550Highwire
Apr 20223300Highwire
May 20222611Highwire
Jun 20222600Highwire
Jul 20223301Highwire
Aug 20222511Highwire
Sep 20221700Highwire
Oct 20222100Highwire
Nov 20223110Highwire
Dec 20222722Highwire
Jan 20233732Highwire
Feb 20231611Highwire
Mar 20237553Highwire
Apr 20231000Highwire
May 2023810Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles